Direkt zum Inhalt
Merck
  • Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.

Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.

Pharmacology (2001-04-05)
T Tadano, M Hozumi, N Satoh, R Oka, T Hishinuma, M Mizugaki, Y Arai, H Yasuhara, H Kinemuchi, F Niijima, O Nakagawasai, K Tan-no, K Kisara
ZUSAMMENFASSUNG

Intraperitoneal injection of benzodiazepine receptor agonists (estazolam, zopiclone, triazolam: 0.03-0.24 mmol/kg) induces the head twitch response (HTR). The present study was undertaken to examine the possible participation of the serotonergic system in the mechanism of head twitches induced by benzodiazepine receptor agonists (BZ-RAs). The HTR induced by BZ-RAs was suppressed by pretreatment with ketanserine (1 mg/kg, i.p.), a selective 5-HT(2) receptor antagonist. Pretreatment with fluoxetine (10 mg/kg, i.p.), a 5-HT reuptake inhibitor, and 8-hydroxy-2-(di-n-propylamino)tetralin, a 5-HT(1A) receptor agonist, also suppressed the HTR induced by BZ-RAs. These results suggest that the HTR induced by BZ-RAs may be the result of an activation of postsynaptic 5-HT(2) receptors, probably due to direct action.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Estazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Estazolam